Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
21%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
IHE
56
HOLDINGS
8%
ALSO IN OZEM
OZEM
22
HOLDINGS
18%
ALSO IN IHE
SECTOR DRIFT (IHE minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 21.4% | 16.2% | 16.2% | |
| PFIZER INC | 4.5% | 7.1% | 4.5% | |
| WAVE LIFE SCIENCES LTD. | 0.3% | 0.4% | 0.3% | |
| MBX BIOSCIENCES INC | 0.2% | 2.0% | 0.2% | |
IHE Overweight Relative to OZEM
| JOHNSON & JOHNSON | 22.4% | |
| ELI LILLY & CO | 5.2% | |
| MERCK & CO. INC. | 4.8% | |
| ROYALTY PHARMA PLC CLASS A | 4.7% | |
| ZOETIS INC | 4.5% | |
| BRISTOL-MYERS SQUIBB CO | 4.5% | |
| VIATRIS, INC. | 4.3% | |
| JAZZ PHARMACEUTICALS PLC | 3.3% | |
| ELANCO ANIMAL HEALTH, INC. | 3.2% | |
| AXSOME THERAPEUTICS, INC. | 2.1% |
IHE Underweight Relative to OZEM
| NOVO-NORDISK A/S-SPONS ADR | -13.2% | |
| VIKING THERAPEUTICS, INC. | -5.5% | |
| INNOVENT BIOLOGICS, INC. | -5.2% | |
| ASCLETIS PHARMA, INC. | -5.0% | |
| AMGEN INC | -3.9% | |
| ASTRAZENECA PLC | -3.9% | |
| HANMI PHARM CO LTD | -3.6% | |
| ZEALAND PHARMA A/S | -3.5% | |
| CHUGAI PHARMACEUTICAL CO LTD | -3.4% | |
| SHANGHAI FOSUN PHARMACEUTI-H | -3.2% |